Copyright
©The Author(s) 2021.
World J Clin Oncol. Aug 24, 2021; 12(8): 702-711
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.702
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.702
Figure 3 Immunohistochemistry of the R12 left breast.
A: Estrogen receptor: Negative; B: Progesterone receptor: Negative; C: CerbB2: Negative; D: E-cadherin: Positive; E: Ki67: 60%.
- Citation: Valencia GA, Rioja P, Morante Z, Araujo JM, Vallejos HD, Guerra H, Gomez HL. PIK3CA mutation in non-metastatic triple-negative breast cancer as a potential biomarker of early relapse: A case report. World J Clin Oncol 2021; 12(8): 702-711
- URL: https://www.wjgnet.com/2218-4333/full/v12/i8/702.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i8.702